GANX Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Gain Therapeutics Inc (GANX) Moving Averages Convergence Divergence (MACD) indicator is -0.0375, suggesting GANX is Strong Sell.

Gain Therapeutics Inc (GANX) 20-Day simple moving average is 1.779, while Gain Therapeutics Inc (GANX) share price is $1.65, making it Sell.

Gain Therapeutics Inc (GANX) 60-Day simple moving average is 1.889, while Gain Therapeutics Inc (GANX) share price is $1.65, making it Sell.

Technical Analysis for GANX

Technical Sentiment Analysis for Gain Therapeutics Inc (GANX) As of 2026-06-09, Gain Therapeutics Inc (GANX) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 10 technical signals, shows that 0 indicators are flashing buy, while 10 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for GANX stands at 40.719, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0375, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 27.276 and the Commodity Channel Index (CCI) at -122.989 further confirm a -0.17 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, GANX is trading below its 60-day moving average of $1.889 and below its 200-day long-term moving average of $2.203. Key price levels to watch include the immediate resistance at $2.061 and strong support at $1.571. A break above $2.061 could signal a bull continuation, while falling below $1.571 may test the next Fibonacci floor at $1.321.

Gain Therapeutics Inc (GANX) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	1.081	1.321	1.571	1.811	2.061	2.301	2.551
Fibonacci	1.321	1.508	1.623	1.811	1.998	2.113	2.301

Gain Therapeutics Inc (GANX) Technical Indicators

2026-06-09

Name	Value
RSI_14	40.719
STOCHk_14_3_3	27.276
STOCHd_14_3_3	39.434
CCI_20	-122.989
AO_5_34	-0.0859
MOM_10	-0.17
MACD_12_26_9	-0.0375

Gain Therapeutics Inc (GANX) Relative Strength Index (RSI) is 40.719, creating a Neutral signal.

Gain Therapeutics Inc (GANX) Stochastic Oscillator is 27.276, creating a Neutral signal.

Gain Therapeutics Inc (GANX) Stochastic RSI is 39.434, creating a Neutral signal.

Gain Therapeutics Inc (GANX) Commodity Channel Index (CCI) is -122.989, creating a Buy signal.

Gain Therapeutics Inc (GANX) Awesome Oscillator is -0.0859, creating a Sell signal.

Gain Therapeutics Inc (GANX) Momentum is -0.17, creating a Sell signal.

Gain Therapeutics Inc (GANX) MACD is -0.0375, creating a Sell signal.

Gain Therapeutics Inc (GANX) Moving Average

2026-06-09

Period	Simple	Signal
MA_5	1.738	Sell
MA_10	1.822	Sell
MA_20	1.779	Sell
MA_60	1.889	Sell
MA_200	2.203	Sell
MA_250	2.097	Sell

Gain Therapeutics Inc (GANX) 5-Day simple moving average is 1.738, while Gain Therapeutics Inc (GANX) share price is $1.65, making it a Sell.

Gain Therapeutics Inc (GANX) 10-Day simple moving average is 1.822, while Gain Therapeutics Inc (GANX) share price is $1.65, making it a Sell.

Gain Therapeutics Inc (GANX) 20-Day simple moving average is 1.779, while Gain Therapeutics Inc (GANX) share price is $1.65, making it a Sell.

Gain Therapeutics Inc (GANX) 60-Day simple moving average is 1.889, while Gain Therapeutics Inc (GANX) share price is $1.65, making it a Sell.

Gain Therapeutics Inc (GANX) 200-Day simple moving average is 2.203, while Gain Therapeutics Inc (GANX) share price is $1.65, making it a Sell.

Gain Therapeutics Inc (GANX) 250-Day simple moving average is 2.097, while Gain Therapeutics Inc (GANX) share price is $1.65, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for GANX?

The overall technical consensus for Gain Therapeutics Inc (GANX) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 0 buy signals and 4 sell signals.

What are the key support and resistance levels for Gain Therapeutics Inc (GANX) today?

Based on pivot point calculations, Gain Therapeutics Inc (GANX) has an immediate support level at 1.571 and a major resistance level at 2.061. Traders also monitor the pivot point at 1.811 to determine the intraday trend direction.

Is Gain Therapeutics Inc (GANX) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Gain Therapeutics Inc (GANX) is currently 40.719. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Gain Therapeutics Inc (GANX)?

Gain Therapeutics Inc (GANX) Moving Averages Convergence Divergence (MACD) indicator is -0.0375, suggesting GANX is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Gain Therapeutics Inc.

How is Gain Therapeutics Inc (GANX) performing relative to its 200-day moving average?

Gain Therapeutics Inc (GANX) is currently trading at $1.65, which is below its 200-day simple moving average of 2.203. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.